• Drug Development

  • Events 

    Tuesday, December 8, 2015 | 8:30 AM - 5:00 PM

    GLP-1 Treatment for Diabetes and Beyond

    Speakers: David D'Alessio (Duke University), Richard DiMarchi (Indiana University), Jean-Philippe Fortin (Pfizer Global), Keld Fosgerau (Zealand Pharma), Matthew Hayes (Perelman School of Medicine, University of Pennsylvania), George Holz (State University of New York), Dong Seok Kim (National Institute on Aging / Peptron Inc), Lotte Bjerre Knudsen (Novo Nordisk), Patrick Sexton (Monash University), Konrad Talbot (Cedars-Sinai Medical Center), Beat Jucker (GlaxoSmithKline)

    GLP-1 receptor agonists have improved treatment options in type 2 diabetes, although realizing their promise in other areas remains challenging. This symposium highlights preclinical and clinical breakthroughs and opportunities for drug development.

    Monday, February 22, 2016 | 9:00 AM - 5:00 PM

    Regenerative Medicine: Transitioning Therapeutics from Cells to the Clinic

    Speakers: Kevin A. D'Amour (Viacyte), John F. DiPersio (Washington University School of Medicine), Edward Lanphier (Sangamo BioSciences), Jane S. Lebkowski (Asterias Biotherapeutics, Inc), Racheli Ofir (Pluristem Therapeutics Inc), Mahendra Rao (The New York Stem Cell Foundation Research Institute), John Sinden (ReNeuron), Katherine Tsokas (Janssen Research and Development, LLC)

    Advances in gene editing cell have driven an explosion of pre-clinical cell based therapies. This event addresses the need to rethink clinical, regulatory & manufacturing approaches to accelerate the transition of drugs through the clinic.

    Monday, February 29, 2016 | 9:00 AM - 5:00 PM

    Emerging Approaches to Cancer Immunotherapy

    Keynote Speakers: Renier Brentjens (Memorial Sloan Kettering Cancer Center), Jedd Wolchok (Memorial Sloan Kettering Cancer Center)
    Speakers: Jane Gross (Emergent Biosolutions, Inc), John Hunter (Compugen Ltd), Jane S. Lebkowski (Asterias Biotherapeutics), Jens-Peter Marschner (Affimed AG), Charles Nicolette (Argos Therapeutics, Inc), Charles L. Sentman (Dartmouth Geisel School of Medicine), Roland Walter (Fred Hutchinson Cancer Research Center)

    Emerging strategies for Cancer Immunotherapy are changing the face of cancer treatment. This symposium will bring together experts in immunotherapy and immunology to discuss emerging approaches, challenges, and opportunities in this evolving field

    March 30 - April 1, 2016

    Sohn Conference: Pediatric Cancer in a Post-genomic World

    Discover the latest on pediatric cancers from leading experts, including etiological differences pediatric and adult cancers, epigenetics, mechanisms of metastasis and disease recurrence, risk factors, diagnostics, and novel treatment approaches.

    April 13 - 14, 2016

    Disease Drivers of Aging: 2016 Advances in Geroscience Summit

    Speakers: Domenico Accili (Columbia University), Timothy Ahles (Memorial Sloan Kettering Cancer Center), Kathryn Anastos (Albert Einstein College of Medicine), Nir Barzilai (Albert Einstein College of Medicine), James Becker (University of Pittsburgh), Caroline Blaum (New York University), Judith Campisi (Buck Institute for Research on Aging), Harvey J. Cohen (Duke University), Steven Deeks (AIDS Research Institute; University of California, San Francisco), Wendy Demark-Wahnefried (University of Alabama at Birmingham), Elissa Epel (University of California, San Francisco), Kristine Erlandson (University of Colorado), Claudia Gravekamp (Albert Einstein College of Medicine), Jeffrey Halter (University of Michigan), Kevin High (Wake Forest University), Arti Hurria (City of Hope National Medical Center), Beth Jamieson (University of California, Los Angeles), C. Ronald Kahn (Joslin Diabetes Center), Balakuntalam Kasinath (UT Health Sciences Center), Gretchen Neigh (Emory University), Rosario Scalia (Temple University), Jan van Deursen (Mayo Clinic)

    Explore how chronic diseases — specifically HIV/AIDS, diabetes, and cancer — can affect the seven mechanistic pillars of aging.

  • Past Events

    October 28 - 29, 2015

    Pre-Approval Access: Can Compassion, Business, and Medicine Coexist?

    This 2-day colloquium will explore challenges surrounding pre-approval access to investigational medicines in a series of debates featuring prominent representatives of governments, pharmaceutical companies, patient groups, NGOs, and foundations.

    Tuesday, October 27, 2015 | 8:00 AM - 5:00 PM

    Phenotypic and Biomarker-Based Drug Discovery

    Speakers: Andras J. Bauer (Boehringer Ingelheim USA), Myles Fennell (Memorial Sloan-Kettering Cancer Center), Michael R. Jackson (Sanford Burnham Prebys Medical Discovery Institute), Jonathan A. Lee (Eli Lilly), Martin Main (AstraZeneca), Friedrich Metzger (F. Hoffmann-La Roche Ltd), Bruce A. Posner (University of Texas, Southwestern Medical Center), Yao Shen (Columbia University), Aravind Subramanian (Broad Institute), Giulio Superti-Furga (Austrian Academy of Sciences), Susanne Swalley (Novartis Institutes for Biomedical Research), Jitao David Zhang (F. Hoffmann-La Roche Ltd.)

    This symposium aims to deepen our understanding of phenotypic drug discovery and to foster the exchange of ideas between industry-based and academic research scientists.

    Thursday, October 15, 2015 | 8:00 AM - 5:00 PM

    Advances in Human Microbiome Science

    Speakers: Jonathan Braun (University of CaliforniaLos Angeles), Rodolphe Clerval (Enterome), Stanislav Dusko Ehrlich (King's College London), Michael A. Fischbach (University of California, San Francisco), Andy Goodman (Yale School of Medicine), Matthew R. Hepworth (Weill Cornell Medical College), Mingzhi Lin (New York University), Randy Longman (Weill Cornell Medical College), Sarkis Mazmanian (California Institute of Technology), Paul O'Toole (University College Cork), Noah W. Palm (Yale University School of Medicine), Tamar Ringel-Kulka (The University of North Carolina at Chapel Hill), R. Balfour Sartor (University of North Carolina School of Medicine)

    In the human colon, the microbiome forms one of the densest bacterial ecosystems known in nature. This symposium will highlight recent research innovations and therapeutic applications from the microbiome with a focus on gut health.

    September 30 - October 1, 2015

    Mobile Health: The Power of Wearables, Sensors, and Apps to Transform Clinical Trials

    Keynote Speakers: Ian Ferguson (ARM), Christian Stammel (Wearable Technologies AG)

    Continuous health monitoring using wearable sensors, mobile devices, and apps is becoming a powerful tool for assessing critical physiological parameters. The vast accumulation of real-time biometric data obtained from these technologies may hold invaluable clues for treating some of the most devastating human diseases.

  • Publications 


    From Tumor Suppressors to Oncogenic Dynamics: The 2015 Dr. Paul Janssen Award Symposium

    Featured Speaker: Bert Vogelstein (Johns Hopkins School of Medicine; Howard Hughes Medical Institute)

    This eBriefing features the work of Bert Vogelstein, recipient of the 2015 Dr. Paul Janssen Award for Biomedical Research, and covers topics at the forefront of precision medicine.


    Antimicrobial Therapeutics Reviews

    Edited by Gerard D. Wright (McMaster University, Ontario, Canada)

    Scholary review articles on mechanisms of antibiotics resistance, new sources of antibiotics, and new techniques in evaluating antibiotic resistance


    Leveraging Big Data and Predictive Knowledge to Fight Disease

    Organizers: Walter Jessen (Covance Inc.), Robert Martone (St. Jude Children's Research Hospital), and Sonya Dougal (The New York Academy of Sciences)
    Keynote Speaker: Niven R. Narain (Berg Pharma)

    This eBriefing explores how big data and predictive knowledge are used to guide drug development and clinical trials.


    Learning from Cancer to Advance Drug Development for Neurodegeneration

    Organizers: Howard Fillit (Alzheimer's Drug Discovery Foundation), Diana Shineman (Alzheimer's Drug Discovery Foundation), and Sonya Dougal (The New York Academy of Sciences)

    This eBriefing explores related research in cancer and neurodegeneration and insights from cancer biology that may advance new therapeutic development for neurodegenerative diseases.